Telesis Bio, Inc.
THIOESTER CATIONIC LIPIDS
Last updated:
Abstract:
The present invention provides, in part, thioester cationic lipid compounds of formula A, and sub-formulas thereof: or a pharmaceutically acceptable salt thereof. The compounds provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, and accordingly can be useful for treating various diseases, disorders and conditions, such as those associated with deficiency of one or more proteins. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
21 Apr 2020
Issue date:
28 Jul 2022